Literature DB >> 30985508

Successful Whole Genome Sequencing-guided Treatment of Mycoplasma hominis Ventriculitis in a Preterm Infant.

Felicia A Scaggs Huang1, Joel Mortensen2, Jesse Skoch3, Heidi Andersen1, Mary Allen Staat1, Joshua K Schaffzin1, David B Haslam1.   

Abstract

We report a case of Mycoplasma hominis ventriculitis in a preterm neonate that was successfully identified with 16S ribosomal RNA sequencing and whole genome sequencing after failure to detect the pathogen with conventional diagnostic methods. The infant required doxycycline with subsequent clearance of the infection and no evidence of drug toxicity.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30985508      PMCID： PMC6565488          DOI： 10.1097/INF.0000000000002306

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  11 in total

1.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

2.  Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.

Authors:  Kevin M Watt; Matthew M Massaro; Brian Smith; Michael Cohen-Wolkowiez; Daniel K Benjamin; Matthew M Laughon
Journal:  Pediatr Infect Dis J       Date:  2012-02       Impact factor: 2.129

Review 3.  Can broad-range 16S ribosomal ribonucleic acid gene polymerase chain reactions improve the diagnosis of bacterial meningitis? A systematic review and meta-analysis.

Authors:  Lakshmi Srinivasan; Jared M Pisapia; Samir S Shah; Casey H Halpern; Mary C Harris
Journal:  Ann Emerg Med       Date:  2012-08-09       Impact factor: 5.721

4.  Mycoplasma hominis Meningitis in a Full-Term Neonate: Rapid Recovery without Specific Treatment.

Authors:  Yan-Fen Huang; Xiao-Ping Mu
Journal:  Indian J Pediatr       Date:  2016-04-25       Impact factor: 1.967

5.  Hypoglycorrhachia in the survivors of neonatal intracranial hemorrhage.

Authors:  O P Mathew; H E Bland; J M Pickens; E J James
Journal:  Pediatrics       Date:  1979-06       Impact factor: 7.124

6.  Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Authors:  S Pereyre; P Gonzalez; B De Barbeyrac; A Darnige; H Renaudin; A Charron; S Raherison; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Ureaplasma urealyticum and Mycoplasma hominis isolation from cervical secretions of pregnant women and nasopharyngeal secretions of their babies at delivery.

Authors:  K B Chua; Y F Ngeow; K B Ng; J K Chye; C T Lim
Journal:  Singapore Med J       Date:  1998-07       Impact factor: 1.858

Review 8.  Mycoplasma hominis meningitis in a neonate: case report and review.

Authors:  Atsuko Hata; Yuiko Honda; Kaoru Asada; Yuko Sasaki; Tsuyoshi Kenri; Daisuke Hata
Journal:  J Infect       Date:  2008-09-14       Impact factor: 6.072

9.  In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.

Authors:  R Krausse; S Schubert
Journal:  Clin Microbiol Infect       Date:  2010-11       Impact factor: 8.067

10.  Kraken: ultrafast metagenomic sequence classification using exact alignments.

Authors:  Derrick E Wood; Steven L Salzberg
Journal:  Genome Biol       Date:  2014-03-03       Impact factor: 13.583
View more
  2 in total

1.  Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Mycoplasma hominis Meningitis in an Extremely Preterm Infant.

Authors:  Telford Yeung; Erin Chung; Jennifer Chen; Laura K Erdman; Mina Smiljkovic; Waison Wong; Asaph Rolnitsky; Shaun K Morris; Amr El Shahed; Rudaina Banihani; Ari Bitnun; Christopher Tomlinson
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10

2.  Prediction of Antimicrobial Resistance in Gram-Negative Bacteria From Whole-Genome Sequencing Data.

Authors:  Pieter-Jan Van Camp; David B Haslam; Aleksey Porollo
Journal:  Front Microbiol       Date:  2020-05-25       Impact factor: 5.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.